相关实验视频

Updated: May 13, 2025

Endoscopic Cholesteatoma Surgery

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

一个单中心回顾性研究儿童恶性ectomesenchymoma的

Yiran Meng¹, Yan Su², Ge Zhang¹

¹Department of Otolaryngology - Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Beijing, 100045, China.

Japanese journal of clinical oncology

|April 13, 2025

概括

结合化疗,手术和放射治疗的恶性内膜瘤 (MEM) 治疗改善了儿童的治疗结果. 这种方法也可以减少不良影响,提高患者的预后.

科学领域:

儿科瘤学儿科瘤学
罕见的癌症罕见的癌症
瘤生物学瘤生物学

背景情况:

恶性肠膜瘤 (MEM) 是一种罕见且具有攻击性的儿科瘤.
了解MEM的临床和病理特征对于有效管理至关重要.

研究的目的:

总结恶性肠膜瘤 (MEM) 的临床和病理特征.
为儿童MEM提供当前治疗选择及其结果的概述.

主要方法:

对2012-2023年间诊断的11例儿科MEM病例进行了回顾性分析.
审查包括手术,化疗和放射治疗在内的治疗方式.
基于治疗方案和瘤标志物 (FOXO1) 的复发率和生存率的分析.

主要成果:

MEM通常会影响头部/部,四肢和骨盆/腹部.
结合化疗和放射治疗的复发率显著降低 (2/6) 与单独化疗相比 (5/5).
FOXO1 ((+) 瘤与较低的存活率有关;5年总体存活率为79%.

结论:

组合疗法 (化疗,手术,放射治疗) 改善了儿科MEM的预后.
放射治疗可能有助于减少MEM患者的不良影响.
进一步研究MEM的分子基础,如FOXO1状态,是有必要的.

关键词:

化疗化疗是一种化学疗法.孩子们的孩子们的孩子们的孩子们.恶性的ectomesenchymomaomaoma可能会发生.辐射疗法辐射疗法手术手术手术手术手术手术手术

更多相关视频

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

相关概念视频

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...